Decreased sensitivity of old and progeric human fibroblasts to a preparation of factors with insulinlike activity.

To determine whether old cells have a reduced response to a preparation of factors from human plasma with insulinlike activity (ILA), we analyzed the response to ILA of early and late passage human fibroblasts from young, old, and progeric donors in the acute stimulation of [3H]2-deoxy-D-glucose (2dG) uptake and the delayed stimulation of [3H]thymidine (TdR) incorporation into DNA. The ILA concentration required to produce equivalent, relative stimulation of TdR incorporation was increased two- to three-fold in late passage cells and cells from old and progeric donors (P less than 0.01). 50 and 95% of maximal stimulation (ILA50, ILA95) was achieved by 0.26 +/- 0.07 and 1.38 +/- 0.13 ng insulin equivalents/ml (mean +/- SD) respectively, in cells from young adults at early passage. Corresponding values were 0.54 +/- 0.05 and 2.90 +/- 0.25 in cells from old donors; greater than 0.9 +/- 0.1 and greater than 3.1 +/- 0.1 in cells from a 9-yr-old progeric donor; and 0.4 +/- 0.05 and 1.1 +/- 0.04 in cells from normal children (9-13 yr). For two cell strains from young adults, ILA50 and ILA95 were 0.30 +/- 0.02 and 1.0 +/- 0.3 ng eq/ml at 30% of their in vitro lifespan completed (%LC) and these values increased at rates of 0.005 ng eq/ml per %LC and 0.04 ng eq/ml per %LC, respectively. The mean stimulation of 2dG uptake ratio (ILA/control) decreased from early to late passage from 2.1 +/- 0.6 to 1.3 +/- 0.1 in young adult donors (P less than 0.05), but there were no significant differences between young and old donors at either early or late passage. The mean stimulation ratio in progeric cells (1.2 +/- 0.2) did not change with in vitro passage, but was significantly lower than that of age-matched normal cells (2.1 +/- 0.8, P less than 0.001). In progeria cells, the reduced stimulation of 2dG uptake upon addition of ILA was due to an increased basal rate of uptake (0.19 +/- 0.01 pmol [3H]2dG/min per mg protein vs. 0.13 +/- 0.01 in age-matched normal cells), and not to a decline in the maximal rate of uptake (0.26 +/- 0.01 vs. 0.27 +/- 0.02, respectively). Similar results were found for in vitro aging in cells from an old donor.

[1]  C. Harley,et al.  Insulin-like peptides stimulate metabolism but not proliferation of human fibroblasts. , 1980, The American journal of physiology.

[2]  C. Kahn,et al.  Direct demonstration of separate receptors for growth and metabolic activities of insulin and multiplication-stimulating activity (an insulinlike growth factor) using antibodies to the insulin receptor. , 1980, The Journal of clinical investigation.

[3]  M. Eden,et al.  Loss of division potential in culture: aging or differentiation? , 1980, Science.

[4]  J. V. Van Wyk,et al.  Evidence from radioligand assays that somatomedin-C and insulin-like growth factor-I are similar to each other and different from other somatomedins. , 1980, The Journal of clinical endocrinology and metabolism.

[5]  R. DeFronzo.  Glucose Intolerance and Aging: Evidence for Tissue Insensitivity to Insulin , 1979, Diabetes.

[6]  L. Phillips,et al.  Characterization of a somatomedin (insulin-like growth factor) synthesized by fetal rat liver organ cultures. , 1979, The Journal of biological chemistry.

[7]  M. Hollenberg,et al.  Receptors for insulin and epidermal growth factor-urogastrone in adult human fibroblasts do not change with donor age , 1979, Mechanisms of Ageing and Development.

[8]  R. Gleason,et al.  Diabetes mellitus and genetic prediabetes. Decreased replicative capacity of cultured skin fibroblasts. , 1979, The Journal of clinical investigation.

[9]  C. Harley,et al.  Partial purification, characterization, and assay of a slightly acidic insulin-like peptide (ILAs) from human plasma. , 1978, The Journal of clinical endocrinology and metabolism.

[10]  M. Eden,et al.  Loss of division potential in vitro: aging or differentiation? , 1978, Science.

[11]  S. Goldstein,et al.  Insulin binding to cultured human fibroblasts increases with normal and precocious aging. , 1976, Science.

[12]  R. Tice,et al.  In vitro Aspects of Human Genetic Disorders which Feature Accelerated Aging , 1976 .

[13]  S. Goldstein,et al.  Heat-labile enzymes in skin fibroblasts from subjects with progeria. , 1975, The New England journal of medicine.

[14]  T. Norwood,et al.  Clonal selection, attenuation and differentiation in an in vitro model of hyperplasia. , 1974, The American journal of pathology.

[15]  S. Goldstein,et al.  Absence of detectable HL-A antigens on cultured fibroblasts in progeria. , 1973, The Journal of clinical investigation.

[16]  R. Andres,et al.  Aging and diabetes. , 1971, The Medical clinics of North America.

[17]  S. Goldstein,et al.  DIABETES MELLITUS AND AGING: DIMINISHED PLATING EFFICIENCY OF CULTURED HUMAN FIBROBLASTS , 1969 .

[18]  S. Goldstein,et al.  Effect of Insulin on the Conversion of Glucose-C-14 to C-14-02 by Normal and Diabetic Fibroblasts in Culture , 1969, Diabetes.

[19]  L. Hayflick.  THE LIMITED IN VITRO LIFETIME OF HUMAN DIPLOID CELL STRAINS. , 1965, Experimental cell research.